Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy

Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy

<h3>Introduction</h3><h4>Cancer Immunotherapy has recently emerged as a promising and effective modality to treat different malignancies. Antigenic profiling of cancer tissues and determination of any pre-existing immune responses to cancer antigens may help predict responses to im...

Full description

Saved in:
Bibliographic Details
Main Author: Afsheen Raza (492657) (author)
Other Authors: Maysaloun Merhi (4246147) (author), Varghese Philipose Inchakalody (14153292) (author), Roopesh Krishnankutty (1297770) (author), Allan Relecom (14153295) (author), Shahab Uddin (154400) (author), Said Dermime (14153298) (author)
Published: 2022
Subjects:
Biomedical and clinical sciences
Immunology
Medical biochemistry and metabolomics
Oncology and carcinogenesis
Cancer immunotherapy
Cancer testis antigen
Cancer vaccine
Immune checkpoint inhibitors
NY-ESO-1
Tumor microenvironment
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items